The question now becomes - was it ethical for @NEJM to publish an early case series that was promoted across the world, and was likely responsible for vast numbers of people receiving remdesivir (perhaps inappropriately)https://twitter.com/peripatetical/status/1253425781260251137 …
-
-
I don't think remdesivir is widely available outside of a clinical trial, so the NEJM case series probably had a tiny fraction of the effect of Raoult's initial HCQ "study".
2 replies 0 retweets 2 likes
Replying to @DrEricStrong @NEJM
True, but stocks still ran very low almost immediately. Both terrible ethically I think
1:50 AM - 24 Apr 2020
0 replies
0 retweets
2 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.